According to a recent market study published by Growth Market Reports, titled, “South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens Market by product type, by material, by application, by end-user, and by Region: Size, Share, Trends and Opportunity Analysis, 2018-2028”, the market was valued at US$ 1,035.4 Million in 2020 and is expected to grow at a growth rate of 12.9% by the year 2028.

Request a free sample copy @ https://growthmarketreports.com/request-sample/2696

Orthokeratology has come a long way since George Jessen proposed it more than 50 years ago. It all started with a programmed sequential fitting of increasingly flat contact lenses to change the anterior corneal curvature and temporarily correct myopia. Modern Ortho-k uses inverted geometry lens designs made from rigid, highly oxygen-permeable materials that are worn at night to reshape the anterior cornea and provide the temporary refractive correction. Orthokeratology (Ortho-k) is a non-surgical treatment. Ortho-k Lens is used in the case of refractive error, and to treatment for myopia.

The South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens market have been fragmented based on product type, material, application, end-user, and region. In terms of product type, the South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens market are categorized as Overnight ortho-k and Daytime Ortho-K. In terms of material, the market is classified as Silicone Acrylate, Fluorosilicone Acrylate, Fluorocarbon Acrylate, Oprifocon A, Others. In terms of application, the market is separated as Myopia, Hypermetropia, Astigmatism, Presbyopia. In terms of end-user, the market is categorized as Hospitals, Ophthalmology Clinics, Vision Care Centers, and others. Considering regions, the South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens market are segmented into South East Asia (SEA), and Asia Pacific (Excluding SEA). Asia Pacific is further separated into, China, Hong Kong, Japan, South Korea, India, Australia and Rest of Asia Pacific. South East Asia is further segregated into Indonesia, Vietnam, Thailand, Malaysia, Singapore, Philippines, Brunei, Burma (Myanmar), Cambodia, Timor-Leste, and Laos.

The COVID-19 outbreak had a negative impact on contact lens production and supply. COVID-19 disrupted economic growth in several emerging countries, including China, Japan, Singapore, South Korea, and India. COVID-19 has created material shortages, labor shortages, health and safety concerns, and other related problems. Manufacturers intend to meet the growing demand for contact lenses by using state-of-the-art technology to increase global revenue generation. The outbreak of the pandemic has slowed the economic growth of the world market. In the Asia Pacific region, the healthcare sector is the main driver of orthokeratology lenses. The COVID-19 pandemic is causing companies and organizations to modify or improvise the use of contact lenses, leading to the rapid adoption of Ortho-k lenses among people with refractive errors. The Ortho-k lens market in China is expected to grow due to the large workforce, the growing geriatric population, and the exporter of raw materials around the world. The market is expected to pick up steam in the second and third quarters of 2021.

As per growth market reports industry analyst Akshata Ahire, “The expanding Healthcare, and Pharmaceutical are expected to contribute to the growth of the South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens Market.

Some of the factors that have aided the growth of the supply chain in advanced economies include the presence of key suppliers and distributors, the availability of raw materials, and the adoption of technology.

Key Takeaways from the Study:

  • The players including the Ortho-k lens market include Bausch & Lomb Incorporated, Brighten Optix.Co, Capricornia Contact Lens, Cooper Vision, Essilor, Euclid Systems Corporation, Gelflex, LUCID KOREA LTD, Menicon Co., Ltd, SEED Co., Ltd, Optact International Co., Ltd, and Visioneering Technologies, Inc. hold a major market share of Ortho-k lens market in year 2020.
  • In terms of product types, the market is segmented into Overnight ortho-k and Daytime Ortho-K. In 2020, the Overnight ortho-k segment had a significant market share and is expected to grow with a substantial CAGR over the forecast period, due to as growing use of an ortho-k lens in children for slowing myopia and other refractive error.
  • Based on applications, the market has split the South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens market is fragmented into Myopia, Hypermetropia, Astigmatism, Presbyopia. The Myopia, segments are expected to grow rapidly over the forecast period due to the increased prevalence of these segments in the healthcare industry.
  • In terms of regions, the South East Asia (SEA) and Asia Pacific (Excluding SEA) Orthokeratology Lens markets are divided into South East Asia (SEA) and Asia Pacific (APAC) (Excluding SEA). The Asia Pacific region had a significant share of the global market in 2020 due to increasing eye disease cases, and technological advancements in contact lenses that are expected to drive the Ortho-k lens market over the forecast period.

Report Scope:

Report Metric

Details

Market Value in 2020

US$ 1,035.4 Million

Market Growth Rate (from 2021 to 2028)

12.9 %

Historical Data

2018 & 2019

Base Year

2020

Forecast Period

2021 - 2028

Units Considered

Value (US$ Million)

Market Segments

by Product Type, by Material, by Application, by End-user, and by Region

Key Companies Profiled

Bausch & Lomb Incorporated, Brighten Optix.Co, Capricornia Contact Lens, Cooper Vision, Essilor, Euclid Systems Corporation, Gelflex, LUCID KOREA LTD, Menicon Co., Ltd, SEED Co., Ltd, Optact International Co., Ltd, and Visioneering Technologies, Inc.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience:

  • Supply-side: Manufacturer and distributors
  • Demand Side: Healthcare, Pharmaceutical, Retail, and Others.
  • Regulatory Side: Concerned government authorities, and other approval regulatory bodies.
  • Associations and Industry Bodies: World Health Organization (WHO), Food Drug Administration (FDA), American Academy of Ophthalmology (AAO), National Institutes of Health (NIH), Global Harmonization Task Force (GHTF), National Medical Products Administration of China (NMPA), Malaysian Society of Ophthalmology (MSO), Orthokeratology Society of Oceania (OSO), American Academy of Orthokeratology and Myopia Control (AAOMC), National Eye Institute (NEI), International Academy of Orthokeratology (IAO) and others.